Follow us
0
×
Home
Shop
What is CBD
Lab Reports
CBD Education
Contact Us
0
Cancer
Home
Docs
Cancer
Home
Docs
Studies
Cancer
Cancer
A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells
A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme
Anandamide Induces Apoptosis in Human Cells via Vanilloid Receptors
* Antiangiogenic activity of the endocannabinoid anandamide: Correlation to its tumor-suppressor efficacy
* Anticancer effects of phytocannabinoids used with chemotherapy in leukaemia cells can be improved by altering the sequence of their administration
Anticancer mechanisms of cannabinoids
* Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer Chemotherapy
Anti-proliferative effects of anandamide in human hepatocellular carcinoma cells
Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy
Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma
Antitumorigenic Effects of Cannabinoids beyond Apoptosis
* Association between cannabis use and the risk of bladder cancer: results from the California Men’s Health Study
Cannabidiol (CBD) Priming Enhances Cisplatin Killing Of Cancer Cells
Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells
Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells
Cannabidiol as potential anticancer drug
Cannabidiol Enhances the Inhibitory Effects of Δ9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival
Cannabidiol Induces Programmed Cell Death in Breast Cancer Cells by Coordinating the Cross-talk between Apoptosis and Autophagy
Cannabidiol inhibits angiogenesis by multiple mechanisms
* Cannabidiol Inhibits Cancer Cell Invasion Via Upregulation Of Tissue Inhibitor Of Matrix Metalloproteinases-1
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism
Cannabidiol Inhibits Growth and Induces Programmed Cell Death in Kaposi Sarcoma–Associated Herpesvirus Infected Endothelium
* Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1
Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy
* Cannabidiolic acid-mediated selective down-regulation of c-fos in highly aggressive breast cancer MDA-MB-231 cells: possible involvement of its down-regulation in the abrogation of aggressiveness
Cannabinoid-associated cell death mechanisms in tumor models (Review)
Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma
Cannabinoid Receptor Agonist as an Alternative Drug in 5-Fluorouracil-resistant Gastric Cancer Cells
Cannabinoid receptor ligands as potential anticancer agents – high hopes for new therapies
Cannabinoid Receptor-Mediated Apoptosis Induced by R()-Methanandamide and Win55,212-2 Is Associated with Ceramide Accumulation and p38 Activation in Mantle Cell Lymphoma
* Cannabinoid receptors as novel targets for the treatment of melanoma
Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non-Small Cell Lung Cancer Growth and Metastasis
* Cannabinoids: A new hope for breast cancer therapy?
* Cannabinoids and cancer
* Cannabinoids and cancer: potential for colorectal cancer therapy
Cannabinoids and cancer: pros and cons of an antitumour strategy
* Cannabinoids and ceramide: two lipids acting hand-by-hand
* Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators
Cannabinoids as therapeutic agents in cancer: current status and future implications
Cannabinoids, Endocannabinoids and Cancer
Cannabinoids for Cancer Treatment: Progress and Promise
Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes
Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas
* Cannabinoids in the treatment of the cachexia-anorexia syndrome in palliative care patients
Cannabinoids: potential antitumoral agents?
Cannabinoids Protect Astrocytes from Ceramide-induced Apoptosis through the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
* Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells
Cannabis and Cannabinoids (PDQ®) – National Cancer Institute | Patient
Cannabis and Cannabinoids (PDQ®) – National Cancer Institute | Healthcare Professional
Cannabis in cancer care
Cannabis Extract Treatment for Terminal Acute Lymphoblastic Leukemia with a Philadelphia Chromosome Mutation
CBD inhibits angiogenesis by multiple mechanisms
* Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer
Clinical Significance of Cannabinoid Receptors CB1 and CB2 Expression in Human Malignant and Benign Thyroid Lesions
Comparison of Orally Administered Cannabis Extract and Delta-9-Tetrahydrocannabinol in Treating Patients With Cancer-Related Anorexia-Cachexia Syndrome: A Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial From the Cannabis-In-Cachexia-Study-Group
COX-2 and PPAR-g Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells
Delta-9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo
* Delta-9-tetrahydrocannabinol interferes with the establishment and the expression of conditioned rejection reactions produced by cyclophosphamide: a rat model of nausea
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized-double-blind, placebo-controlled pilot trial
* Differential role of cannabinoids in the pathogenesis of skin cancer
Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells
Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study
* Endocannabinoids and Cancer
* Endocannabinoids and fatty acid amides in cancer inflammation and related disorders
Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (Review)
Endocannabinoids as Guardians of Metastasis
Endocannabinoids in endocrine and related tumours
Enhancing the Activity of Cannabidiol and Other Cannabinoids In Vitro Through Modifications to Drug Combinations and Treatment Schedules
Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa
Exogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress: involvement of cannabinoid axis in liver cancer cells
Expression and Functional Relevance of Cannabinoid Receptor 1 in Hodgkin Lymphoma
Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: Growth inhibition by receptor activation
High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma
Id-1 Is a Key Transcriptional Regulator of Glioblastoma Aggressiveness and a Novel Therapeutic Target
Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor
In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma
Increasing Antiproliferative Properties of Endocannabinoids in N1E-115 Neuroblastoma Cells through Inhibition of Their Metabolism
Inhibition of Cancer Cell Invasion by Cannabinoids via Increased Expression of Tissue Inhibitor of Matrix Metalloproteinases-1
Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors
* Inhibition of tumor angiogenesis by cannabinoids
Integrating cannabis into clinical cancer care
Involvement of PPARc in the antitumoral action of cannabinoids on hepatocellular carcinoma
Loss of Cannabinoid Receptor 1 Accelerates Intestinal Tumor Growth
Marijuana Use and the Risk of Lung and Upper Aerodigestive Tract Cancers: Results of a Population-Based Case-Control Study
Medical marijuana for cancer
Medical Marijuana Use in Oncology
Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying Cannabinoid-Mediated
Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent
Modulation of LPS-Induced Activation of BV-2 Microglial Cells
Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC: CBD extract and THC extract in patients with intractable cancer-related pain
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms
NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies)
Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation
Potentiation of Cannabinoid-Induced Cytotoxicity in Mantle Cell Lymphoma through Modulation of Ceramide Metabolism
Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2
* Preparation and characterisation of biodegradable microparticles filled with THC and their antitumor efficacy on cancer cell lines
Proapoptotic effect of endocannabinoids in prostate cancer cells
Receptor-dependent and Receptor-independent Endocannabinoid Signaling: A Therapeutic Target for Regulation of Cancer Growth
Regulation of nausea and vomiting by cannabinoids
* Structure-dependent inhibitory effects of synthetic cannabinoids against 12-O-tetradecanoylphorbol-13-acetate-induced inflammation and skin tumour promotion in mice
Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease
Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
The cannabinoids: An overview. Therapeutic implications in vomiting and nausea after cancer chemotherapy, in appetite promotion, in multiple sclerosis and in neuroprotection
* The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway
The combination of cannabidiol and Δ9-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model
The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2
The endocannabinoid system and cancer: therapeutic implication
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation
The Expression Level of CB1 and CB2 Receptors Determines Their Efficacy at Inducing Apoptosis in Astrocytomas
The Medical Necessity for Medicinal Cannabis: Prospective, Observational Study Evaluating the Treatment in Cancer Patients on Supportive or Palliative Care
The potential relevance of the endocannabinoid, 2- arachidonoylglycerol, in diffuse large B-cell lymphoma
The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications
The role of cannabinoids in the treatment of children with cancer
The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells
The use of cannabinoids as anticancer agents
* Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis
* Towards the use of cannabinoids as antitumour agents
U
nited States patent application publication for phytocannabinoids in the treatment of cancer
Epstein-Barr Virus
Arnold-Chiari Malformation and Syringomyelia
Want to know about our offers first?
Subscribe our newsletter
Subscribe
Leave this field empty if you're human:
[elfsight_social_icons id=”1″]
ARE YOU OF LEGAL SMOKING AGE?
Yes
No